These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 89091)
1. Inactivators of fibroblast interferon found in human serum. Cesario T; Vaziri N; Slater L; Tilles J Infect Immun; 1979 Jun; 24(3):851-5. PubMed ID: 89091 [TBL] [Abstract][Full Text] [Related]
2. Interferon inhibitors and/or inactivators in sera from patients with neoplasias. Tsantakis G; Schizas N; Havredaki M Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):335-7. PubMed ID: 7516650 [TBL] [Abstract][Full Text] [Related]
3. Inactivation of human interferon by body fluids. Cesario TC; Tilles JG Tex Rep Biol Med; 1977; 35():443-8. PubMed ID: 616673 [TBL] [Abstract][Full Text] [Related]
4. A pressure ultrafiltration method for serum free drug determination. Comparison with equilibrium dialysis using normal and uraemic sera. Tiula E Methods Find Exp Clin Pharmacol; 1984 Jan; 6(1):51-5. PubMed ID: 6717171 [TBL] [Abstract][Full Text] [Related]
5. Interferon and interferon inactivators in patients with acquired immune deficiency syndrome and Kaposi's sarcoma. A preliminary report. Ikossi-O'Connor MG; Ambrus JL; West T; Lillie MA; Milgrom H; Chadha KC Res Commun Chem Pathol Pharmacol; 1984 Aug; 45(2):271-7. PubMed ID: 6207572 [TBL] [Abstract][Full Text] [Related]
6. Middle molecules in uremic serum, urine and dialysis fluid. Migone L; Dall'taglio P; Buzio C Clin Nephrol; 1975; 3(3):82-93. PubMed ID: 1139803 [TBL] [Abstract][Full Text] [Related]
7. Lipid metabolism in uremia: effect of regular hemofiltration and hemodialysis treatment. Henning HV; Balusek E J Dial; 1977; 1(6):595-605. PubMed ID: 608870 [TBL] [Abstract][Full Text] [Related]
8. The use of hemoperfusion as an adjunct to hemodialysis. Trafford A; Ireland R; Evans R Artif Organs; 1979 Aug; 3(3):249-52. PubMed ID: 533415 [TBL] [Abstract][Full Text] [Related]
9. Serum chromatographic pattern in different dialysis strategies. Ringoir S; De Smet R Int J Artif Organs; 1978 Sep; 1(5):218-23. PubMed ID: 689764 [TBL] [Abstract][Full Text] [Related]
10. Liquid-chromatographic profiling of endogenous fluorescent substances in sera and urine of uremic and normal subjects. Mabuchi H; Nakahashi H Clin Chem; 1983 Apr; 29(4):675-7. PubMed ID: 6831696 [TBL] [Abstract][Full Text] [Related]
11. Fluorescent substances in uremic and normal serum. Shaykh M; Bazilinski N; McCaul DS; Ahmed S; Dubin A; Musiala T; Dunea G Clin Chem; 1985 Dec; 31(12):1988-92. PubMed ID: 4064287 [TBL] [Abstract][Full Text] [Related]
12. Mouse fibroblast (type I) and immune (type II) interferons: pronounced differences in affinity for gangliosides and in antiviral and antigrowth effects on mouse leukemia L-1210R cells. Ankel H; Krishnamurti C; Besançon F; Stefanos S; Falcoff E Proc Natl Acad Sci U S A; 1980 May; 77(5):2528-32. PubMed ID: 6156452 [TBL] [Abstract][Full Text] [Related]
13. Serum uremic toxins from patients with chronic renal failure displace the binding of L-tryptophan to human serum albumin. Mingrone G; De Smet R; Greco AV; Bertuzzi A; Gandolfi A; Ringoir S; Vanholder R Clin Chim Acta; 1997 Apr; 260(1):27-34. PubMed ID: 9101098 [TBL] [Abstract][Full Text] [Related]
14. Defective cellular immunity in renal failure: depression of reactivity of lymphocytes to phytohemagglutinin by renal failure serum. Newberry WM; Sanford JP J Clin Invest; 1971 Jun; 50(6):1262-71. PubMed ID: 5578233 [TBL] [Abstract][Full Text] [Related]